Q: please give me your opinion on the result of wsp
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: HCG investors may be interested in this Financial Post article, dated Jul. 28.
http://business.financialpost.com/investing/market-moves/home-capital-group-inc-shares-fall-the-most-since-facing-mortgage-fraud-fallout-in-2015?__lsa=c53a-f671
http://business.financialpost.com/investing/market-moves/home-capital-group-inc-shares-fall-the-most-since-facing-mortgage-fraud-fallout-in-2015?__lsa=c53a-f671
Q: What are your thoughts on AKT.A, it popped up on my filters for low debt to equity, growing dividend.... but surprises me considering the sector it's in.
Q: your take on earnings, the revenue number seems great, but the losing money part seems worrisome even though they forecast it. dave
Q: Please help me understand the Target Price spreadsheet. I see companies with forecasted price declines with many Buy and some Strong Buy ratings. Huh? Please provide some context for the source of the data. Thx Frank
Q: The company seems to be overpriced as they are still losing cash. They have many competitors in all their sectors. Also, IMAX just closed a huge deal with China's biggest cinema operator committing to 150 IMAX screens, which reduces available space for potential D-BOX screens. As mass market adoption of virtual reality isn't yet a sure thing, would it be safe to sell this stock and rebuy it when on a big pull back? Thanks!
Q: hi team
your opinion,please,on serona sbm.
gaston
your opinion,please,on serona sbm.
gaston
Q: As we all mention, thanks for the great work. WPK seems to be trending lower. Their results did not seem too bad. What are your views going forward. David
Q: A question that has preplexed me for a long time is how should we, as investors, interpret a recommendation to "hold"? This term is used by virtually everyone in the investing community. And I am not referring here specifically to the target price data recently posted.
It seems to me that everyone should only want to always be owning stocks that are either doing well or they feel have the potential to do well - i.e. a "buy" (at least in their own mind) A "hold" signal to me suggests that the stock is in neutral and the analyst has little conviction as to whether it is a buy or sell. Therefore, shouldn't I only want to own stocks that are just "buys"? Whenever I look at my holdings, I am always asking myself if this is the best stock I can own for the long term because I am interested in overall results 5 years from now keeping sector allocation in mind). I have hung on to AVO, for example, because I still feel that the potential returns are better than anything else I can find in the sector. But I sold BTE because I didn't see a future there. Trading costs shouldn't be part of the answer as it only costs me $5 for each trade.
Appreciate yor insight.
Paul F.
It seems to me that everyone should only want to always be owning stocks that are either doing well or they feel have the potential to do well - i.e. a "buy" (at least in their own mind) A "hold" signal to me suggests that the stock is in neutral and the analyst has little conviction as to whether it is a buy or sell. Therefore, shouldn't I only want to own stocks that are just "buys"? Whenever I look at my holdings, I am always asking myself if this is the best stock I can own for the long term because I am interested in overall results 5 years from now keeping sector allocation in mind). I have hung on to AVO, for example, because I still feel that the potential returns are better than anything else I can find in the sector. But I sold BTE because I didn't see a future there. Trading costs shouldn't be part of the answer as it only costs me $5 for each trade.
Appreciate yor insight.
Paul F.
-
iShares S&P/TSX Global Gold Index ETF (XGD)
-
Global X Gold ETF (HUG)
-
iShares Gold Bullion ETF (CGL.C)
Q: I have a large portfolio of 1.3 Mil in value. They are accross all sectors. I will be adding another 200k shortly. I have no precious metals in my portfolio as I was not comfortable with the volatility. What would you suggest for percentage amount of precious metals and what companies, ETF's
would you suggest. Is holding physical gold less volatile that companies?
If so, is there an ETF that holds physical gold.
would you suggest. Is holding physical gold less volatile that companies?
If so, is there an ETF that holds physical gold.
Q: I am not looking for a full review. We have the following stocks. Which ones stand out to be dropped and replaced with what?
KXS, CXR, ESL, DH, SYZ, MDA, SIS, CCL.B, GUD, PBH, FR.
PUR, BCI, DRT, FSV, DHX.B, XTC, DSG, WCP, NFI, CSU,
ENB, STN, WSP, BEP.UN, SGY.
Thank you for your great service
PB
KXS, CXR, ESL, DH, SYZ, MDA, SIS, CCL.B, GUD, PBH, FR.
PUR, BCI, DRT, FSV, DHX.B, XTC, DSG, WCP, NFI, CSU,
ENB, STN, WSP, BEP.UN, SGY.
Thank you for your great service
PB
Q: I am sure by now 5i must roll its collective eyes at the sight of another CXR question.
I don't own the stock but find it fascinating. Some analysts predict 2017 earnings to be $4-5 per share or even higher. Globeinvestor has their debt to equity at about 3x. My questions are these:
1. what is the major risk that the anticipated earnings don't materialize? gov't intervention? or is there fear that like Valiant there may be some misrepresentation on the books?
2. if debt to capital is 3x, that would mean that there is approx. $60 of debt per share, given a $20 share price. correct?
3. if they are paying an average of 5% interest on their debt, wouldn't interest alone eat most of their earnings? i.e. $3 per share would go just to interest. seems like it would take a very long time to get out of debt.
4. seems like it will be almost impossible for this company to grow by acquisition for a long time, given the environment. almost like a game of musical chairs where the music has stopped for a final time and there is no reason now to own the stock other than value. true?
Thanks for your patience with us as we try to figure this market out.
Cheers
John
I don't own the stock but find it fascinating. Some analysts predict 2017 earnings to be $4-5 per share or even higher. Globeinvestor has their debt to equity at about 3x. My questions are these:
1. what is the major risk that the anticipated earnings don't materialize? gov't intervention? or is there fear that like Valiant there may be some misrepresentation on the books?
2. if debt to capital is 3x, that would mean that there is approx. $60 of debt per share, given a $20 share price. correct?
3. if they are paying an average of 5% interest on their debt, wouldn't interest alone eat most of their earnings? i.e. $3 per share would go just to interest. seems like it would take a very long time to get out of debt.
4. seems like it will be almost impossible for this company to grow by acquisition for a long time, given the environment. almost like a game of musical chairs where the music has stopped for a final time and there is no reason now to own the stock other than value. true?
Thanks for your patience with us as we try to figure this market out.
Cheers
John
Q: my cost on CXR is 23.50 . what would be my downside risk at these levels? I keep hearing about a strategic review. what does this entail and what impact can this have on the stock price?
Q: http://investors.cvshealth.com/~/media/Files/C/CVS-IR-v3/documents/02-aug-2016/2017-standard-formulary-list-of-removals-and-updates.pdf
This may be another part of the reason for the sell-off today. Nilandron appears to have been added to the list of drugs to be removed at CVS for 2017 due to hyperinflation. I'm not sure of the implications as far as the percent of Nilandron historically sold through CVS. I would assume they'd re-negotiate pricing and take a bit of a hit?
This may be another part of the reason for the sell-off today. Nilandron appears to have been added to the list of drugs to be removed at CVS for 2017 due to hyperinflation. I'm not sure of the implications as far as the percent of Nilandron historically sold through CVS. I would assume they'd re-negotiate pricing and take a bit of a hit?
Q: Thanks for the bonus report. It is very helpful.
Can you please advise which sector each stock belong too.
Do you have any site where I can find sector information.
Are you planning to create sector information.
SANDVINE CORP
Evertz Technologies Ltd
Savaria Corp
EnerCare Inc
Intertain Group
TRICON CAPITAL GROUP INC
ALTAGAS
Shawcor Ltd
CHARTWELL RETIREMENT RESIDENCES
Sienna Senior Living Inc
Visa
Thanks for the great service
Can you please advise which sector each stock belong too.
Do you have any site where I can find sector information.
Are you planning to create sector information.
SANDVINE CORP
Evertz Technologies Ltd
Savaria Corp
EnerCare Inc
Intertain Group
TRICON CAPITAL GROUP INC
ALTAGAS
Shawcor Ltd
CHARTWELL RETIREMENT RESIDENCES
Sienna Senior Living Inc
Visa
Thanks for the great service
Q: FRU is off 4% today, while energy index(XEG) is only off 2.75%.
Is A BUYING OPPORTUNITY?. iF not at what price would it be?
Is A BUYING OPPORTUNITY?. iF not at what price would it be?
Q: Where can you get company bond information, quotes, etc.?
Q: Peter & Team, as to the question from Dennis today, the company needs to begin reporting organic growth in Covis and AMCO, preferably be summarized product category. We cannot wait until they cycle up against these acquisitions by end of year to see comparables; we need to know if things are better or worse from when they bought these products. And we need to know it August 12th when they report the quarter.
Reporting against target EBITDA of $610 to $640 million and Net Debt/EBITDA of 5.5x is not cutting it (obviously).
If management won't disclose product growth prior to acquisition date or if there is no constant currency growth, would that not be 5i's cue to cut and run?
Thank you.
Reporting against target EBITDA of $610 to $640 million and Net Debt/EBITDA of 5.5x is not cutting it (obviously).
If management won't disclose product growth prior to acquisition date or if there is no constant currency growth, would that not be 5i's cue to cut and run?
Thank you.
Q: Husky has been nasty. Big drop, cut its dividend and seems to be wallowing. Is there any hope for it or should I bite the bullet, sell at a big loss, and look to invest in something more hopeful? It's in a registered account, so I can't claim the loss.
Q: Seeing all of the questions about the big drop today and having purchased at higher levels i agree that it's a really frustrating stock. However, i read today that Taylor Asset Management (David Taylor of Dynamic fund fame) and Davis Rea (John O'Connell) actually added to their positions at the end of Q2. They seem to be looking at the fundamentals without emotion and see the value in the company